Published in Methods Mol Biol on January 01, 2014
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97
Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. J Rheumatol (2003) 1.77
Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS One (2012) 1.63
Use of polymerase chain reaction to diagnose tuberculous arthritis from joint tissues and synovial fluid. Arch Pathol Lab Med (2004) 1.63
Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum (2011) 1.54
Revision total knee arthroplasty: 1990 through 2002. A review of the Finnish arthroplasty registry. J Bone Joint Surg Am (2006) 1.52
Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop (2009) 1.48
Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants. J Rheumatol (2005) 1.46
Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.46
Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs. Clin Rheumatol (2013) 1.42
Corneal innervation and morphology in primary Sjögren's syndrome. Invest Ophthalmol Vis Sci (2003) 1.41
Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty (2008) 1.37
Mesenchymal stem cells and cardiac repair. J Cell Mol Med (2008) 1.37
Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome. Exp Eye Res (2008) 1.36
Younger age increases the risk of early prosthesis failure following primary total knee replacement for osteoarthritis. A follow-up study of 32,019 total knee replacements in the Finnish Arthroplasty Register. Acta Orthop (2010) 1.34
Low rate of infected knee replacements in a nationwide series--is it an underestimate? Acta Orthop (2009) 1.32
Prevention of deep infection in joint replacement surgery. Acta Orthop (2010) 1.28
Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun (2012) 1.24
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
Alternative materials to improve total hip replacement tribology. Acta Orthop Scand (2003) 1.18
Macrophages-Key cells in the response to wear debris from joint replacements. J Biomed Mater Res A (2013) 1.18
Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun (2013) 1.18
Bioabsorbable miniplating versus metallic fixation for metacarpal fractures. Clin Orthop Relat Res (2003) 1.17
Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol (2002) 1.16
Amyloidosis-recent developments. Semin Arthritis Rheum (2008) 1.14
Total hip replacement in patients eighty years of age and older. J Bone Joint Surg Am (2008) 1.12
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives. Autoimmun Rev (2011) 1.07
Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab (2009) 1.06
Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Biochemistry (2003) 1.04
Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med (2011) 1.03
Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants. J Rheumatol (2009) 1.02
Human osteoblasts produce cathepsin K. Bone (2005) 1.00
Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles. J Orthop Res (2011) 0.99
Bone stress injuries of the lower extremity: a review. Acta Orthop Scand (2002) 0.98
Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol (2011) 0.97
Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome. Curr Rheumatol Rep (2003) 0.96
Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision. Knee Surg Sports Traumatol Arthrosc (2012) 0.95
Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis. Arthritis Rheum (2010) 0.95
Epithelial-mesenchymal transition downregulates laminin alpha5 chain and upregulates laminin alpha4 chain in oral squamous carcinoma cells. Histochem Cell Biol (2008) 0.94
Basement membrane collagen type IV expression by human mesenchymal stem cells during adipogenic differentiation. J Cell Mol Med (2012) 0.93
Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells. Tohoku J Exp Med (2004) 0.93
Microbial antigens mediate HLA-B27 diseases via TLRs. J Autoimmun (2009) 0.92
Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anticancer Drugs (2002) 0.92
Toll-like receptors in the interface membrane around loosening total hip replacement implants. J Biomed Mater Res A (2007) 0.92
Titanium particles modulate expression of Toll-like receptor proteins. J Biomed Mater Res A (2010) 0.91
Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome. J Rheumatol (2008) 0.90
Biotechnological advances in neuro-electro-stimulation for the treatment of hyposalivation and xerostomia. Med Oral Patol Oral Cir Bucal (2009) 0.90
Revision total knee arthroplasty with the total condylar III system: a comparative analysis of 71 consecutive cases of osteoarthritis or inflammatory arthritis. Acta Orthop (2006) 0.90
Chemical and physical properties of regenerative medicine materials controlling stem cell fate. Ann Med (2011) 0.90
Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre- and postmenopausal women. Aging Cell (2011) 0.90
Chronic arthritis leads to disturbances in the bone collagen network. Arthritis Res Ther (2010) 0.90
Collagen network of articular cartilage modulates fluid flow and mechanical stresses in chondrocyte. Biomech Model Mechanobiol (2006) 0.89
Collagenolytic proteinases in keratoconus. Cornea (2006) 0.89
Reduction of wear in total hip replacement prostheses by amorphous diamond coatings. J Biomed Mater Res B Appl Biomater (2003) 0.89
Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression. Clin Rev Allergy Immunol (2014) 0.89
Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome. Arthritis Rheum (2007) 0.89
Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. J Rheumatol (2005) 0.89
The response of macrophages to titanium particles is determined by macrophage polarization. Acta Biomater (2013) 0.89
EMMPRIN and MMP-1 in keratoconus. Cornea (2006) 0.89
Distribution of shear stress over smooth muscle cells in deformable arterial wall. Med Biol Eng Comput (2008) 0.89
Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay. Clin Biochem (2010) 0.89
Upregulation of matrix metalloproteinase (MMP)-1 and its activator MMP-3 of human osteoblast by uniaxial cyclic stimulation. J Biomed Mater Res B Appl Biomater (2007) 0.88
Toll-like receptors in human chondrocytes and osteoarthritic cartilage. Acta Orthop (2013) 0.88
Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses. J Rheumatol (2003) 0.88
Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level. PLoS One (2013) 0.88
Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome. Arthritis Rheum (2004) 0.88
The influence of sex steroids on Sjögren's syndrome. Ann N Y Acad Sci (2007) 0.88
A novel metalloprotease from Vipera lebetina venom induces human endothelial cell apoptosis. Toxicon (2005) 0.87
Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals? J Orthop Res (2010) 0.87
Variations of neuronal nitric oxide synthase in systemic sclerosis skin. Arthritis Rheum (2006) 0.87
Plasmin-matrix metalloproteinase cascades in spinal response to an experimental disc lesion in pig. Spine (Phila Pa 1976) (2008) 0.87
Oral treatment options for degenerative joint disease--presence and future. Adv Drug Deliv Rev (2006) 0.87
Outcomes of switching anti-TNF drugs in rheumatoid arthritis--a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN). Clin Rheumatol (2011) 0.86
Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants. J Biomed Mater Res A (2010) 0.86
The effect of pulsed electromagnetic fields and dehydroepiandrosterone on viability and osteo-induction of human mesenchymal stem cells. J Tissue Eng Regen Med (2012) 0.85
Modulation of mouse macrophage polarization in vitro using IL-4 delivery by osmotic pumps. J Biomed Mater Res A (2014) 0.85
Do changing toll-like receptor profiles in different layers and grades of osteoarthritis cartilage reflect disease severity? J Rheumatol (2013) 0.85
Enhanced osteolytic potential of monocytes/macrophages derived from bone marrow after particle stimulation. J Biomed Mater Res B Appl Biomater (2008) 0.85
Self-reinforced bioabsorbable versus metallic fixation systems for metacarpal and phalangeal fractures: a biomechanical study. J Hand Surg Am (2002) 0.85
Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. PLoS One (2011) 0.85
Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands. J Immunol (2006) 0.85
Neuroelectrostimulation in treatment of hyposalivation and xerostomia in Sjögren's syndrome: a salivary pacemaker. J Rheumatol (2008) 0.85
Characterization of macrophage polarizing cytokines in the aseptic loosening of total hip replacements. J Orthop Res (2014) 0.85
Arthroscopic operations in joint tuberculosis. Knee (2004) 0.84
Update on UHMWPE research: from the bench to the bedside. Acta Orthop (2008) 0.84
Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate. J Surg Res (2003) 0.84
Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study. Semin Arthritis Rheum (2013) 0.84
Adhesion of staphylococcal and Caco-2 cells on diamond-like carbon polymer hybrid coating. J Biomed Mater Res A (2008) 0.84
Valsalva leak point pressure-associated Q-tip angle and simple female stress urinary incontinence symptoms. Int Urol Nephrol (2014) 0.83
Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue. Am J Pathol (2005) 0.83